T-ALL leukemia stem cell 'stemness' is epigenetically controlled by the master regulator SPI1

Author:

Zhu Haichuan123,Zhang Liuzhen123,Wu Yilin123,Dong Bingjie123,Guo Weilong123ORCID,Wang Mei123ORCID,Yang Lu123,Fan Xiaoying123,Tang Yuliang24,Liu Ningshu5,Lei Xiaoguang24,Wu Hong123ORCID

Affiliation:

1. The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing, China

2. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China

3. Beijing Advanced Innovation Center for Genomics, Peking University, Beijing, China

4. Department of Chemical Biology, College of Chemistry and Molecular Engineering, Peking University, Beijing, China

5. Drug Discovery Oncology, Bayer Pharmaceuticals, Berlin, Germany

Abstract

Leukemia stem cells (LSCs) are regarded as the origins and key therapeutic targets of leukemia, but limited knowledge is available on the key determinants of LSC ‘stemness’. Using single-cell RNA-seq analysis, we identify a master regulator, SPI1, the LSC-specific expression of which determines the molecular signature and activity of LSCs in the murine Pten-null T-ALL model. Although initiated by PTEN-controlled β-catenin activation, Spi1 expression and LSC ‘stemness’ are maintained by a β-catenin-SPI1-HAVCR2 regulatory circuit independent of the leukemogenic driver mutation. Perturbing any component of this circuit either genetically or pharmacologically can prevent LSC formation or eliminate existing LSCs. LSCs lose their ‘stemness’ when Spi1 expression is silenced by DNA methylation, but Spi1 expression can be reactivated by 5-AZ treatment. Importantly, similar regulatory mechanisms may be also present in human T-ALL.

Funder

National Natural Science Foundation of China

National Key Research

Center for Life Sciences

Beijing Advanced Innovation Center for Genomics

Bayer

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3